Pharmaceutical intermediates are compounds used during the synthesis of active pharmaceutical ingredients (APIs). They are intermediate products in the chemical process that ultimately leads to the production of the final API. They can be used to make drugs for various therapeutic areas, including cancer, cardiovascular diseases, and central nervous system disorders. Pharmaceutical intermediates play a crucial role in determining the quality, purity, and stability of the final API, and therefore, their manufacturing and quality control are strictly regulated by government agencies. The proper selection and control of pharmaceutical intermediates is critical to ensuring the safety and efficacy of the final API.
-
Propargyl p-toluenesulfonate CAS6165-76-0Pharmaceutical intermediates, general reagents
-
2-(4-Bromomethyl)phenylpropionic acid CAS111128-12-2As the intermediate of pharmaceutical synthesi
-
4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pymol[2,3-d]pyrimodin-5-yl)ethyl]benzoic acid CAS137281-39-1Pemetrexed disodium intermediates
-
5`-deoxy-5-fluore-N-[(pentoyloxy)carbonyl]cytidine 2`,3`-diacetate CAS162204-20-8Antitumor drug capecitabine intermediates
-
[1,3-Bis(diphenylphosphino)propane] dichloronickel CAS15629-92-2Medicine and OLED intermediates
-
Tricyclohexylphosphonium tetrafluoroborate CAS58656-04-5Medicine and OLED intermediates
-
2,7-Dibromo-9,9'-spiro-bifluorene, CAS171408-84-7Pharmaceutical intermediates, also is important intermediates for the synthesis of photoelectric material
-
2-Bromo-9,9'-spirobifluorene CAS171408-76-7Pharmaceutical intermediates, also is important intermediates for the synthesis of photoelectric material
-
2,7-Di-tert-butylfluorene CAS58775-05-6Pharmaceutical intermediates, also is important intermediates for the synthesis of photoelectric material